Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Market Cap : $476.40 Mil (As of Apr. 28, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Clinuvel Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was $10.52. Clinuvel Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 50.13 Mil. Therefore, Clinuvel Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was $527.34 Mil.

Clinuvel Pharmaceuticals's quarterly market cap declined from Dec. 2022 ($689.77 Mil) to Jun. 2023 ($592.92 Mil) and declined from Jun. 2023 ($592.92 Mil) to Dec. 2023 ($527.34 Mil).

Clinuvel Pharmaceuticals's annual market cap declined from Jun. 2021 ($1,061.09 Mil) to Jun. 2022 ($481.75 Mil) but then increased from Jun. 2022 ($481.75 Mil) to Jun. 2023 ($592.92 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Clinuvel Pharmaceuticals's Enterprise Value for Today is $363.31 Mil.

Clinuvel Pharmaceuticals Market Cap Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Market Cap Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Market Cap

Get a 7-Day Free Trial

1,158.90

845.41

1,061.09

481.75

592.92

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial															1,005.01	481.75	689.77	592.92	527.34

Competitive Comparison of Clinuvel Pharmaceuticals's Market Cap

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Market Cap falls into.

Clinuvel Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Clinuvel Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )	=	Share Price (A: Jun. 2023 )	*	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	$12	*	49.4103
	=	$592.92

Clinuvel Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	$10.52	*	50.1273
	=	$527.34

Clinuvel Pharmaceuticals (OTCPK:CLVLF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Clinuvel Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.